Journal
OPEN FORUM INFECTIOUS DISEASES
Volume 5, Issue 1, Pages -Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofx277
Keywords
antimicrobials; end-of-life; oritavancin; palliative care
Categories
Funding
- Yale School of Medicine, Section of Infectious Diseases [2T32AI007517-16]
Ask authors/readers for more resources
Administering and monitoring intravenous antimicrobials may cause discomfort in patients at the end of life and delay transition to hospice. We describe 3 patients with terminal cancer with methicillin-resistant Staphylococcus aureus, Streptococcus gallolyticus, and Granulicatella adiacens bacteremia who were managed with the long-acting lipoglycopeptide oritavancin to facilitate discharge to hospice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available